Sapna Shah Acquires 20,000 Shares of BioPharma Credit (LON:BPCR) Stock

BioPharma Credit (LON:BPCRGet Free Report) insider Sapna Shah acquired 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 27th. The stock was bought at an average price of GBX 72 ($0.91) per share, with a total value of £14,400 ($18,197.90).

BioPharma Credit Stock Down 2.9 %

LON BPCR opened at GBX 0.87 ($0.01) on Friday. The company has a market capitalization of £11.31 million, a price-to-earnings ratio of 6.69 and a beta of 0.21. BioPharma Credit has a twelve month low of GBX 0.81 ($0.01) and a twelve month high of GBX 1.02 ($0.01). The stock has a fifty day simple moving average of GBX 0.90 and a 200 day simple moving average of GBX 0.87.

BioPharma Credit Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Tuesday, April 30th. Investors of record on Thursday, March 28th will be issued a $0.02 dividend. The ex-dividend date is Thursday, March 28th. This represents a yield of 1.97%. BioPharma Credit’s payout ratio is 5,384.62%.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

Read More

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.